Balsalazide is a prodrug of the anti-inflammatory agent 5-aminosalicylic acid , which is effective against Crohn’s disease and ulcerative colitis in animal models and clinical trials. The azo bond of balsalazide is cleaved by bacterial azo reductases in the gut to generate the active derivative.
